177 related articles for article (PubMed ID: 25740182)
1. VTE risk assessment in cancer. Who needs prophylaxis and who does not?
Ay C; Pabinger I
Hamostaseologie; 2015; 35(4):319-24. PubMed ID: 25740182
[TBL] [Abstract][Full Text] [Related]
2. Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis?
Pabinger I; Ay C
Hamostaseologie; 2012; 32(2):132-7. PubMed ID: 21822526
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, risk and outcomes of venous thromboembolism in cancer.
Falanga A; Russo L
Hamostaseologie; 2012; 32(2):115-25. PubMed ID: 21971578
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
Thaler J; Ay C; Pabinger I
Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
[TBL] [Abstract][Full Text] [Related]
6. Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
Aikens GB; Rivey MP; Hansen CJ
Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067
[TBL] [Abstract][Full Text] [Related]
7. [Thromboprophylaxis in ambulatory patients with cancer].
Hart C; Heudobler D; Linnemann B
Dtsch Med Wochenschr; 2020 Feb; 145(3):130-134. PubMed ID: 32018283
[TBL] [Abstract][Full Text] [Related]
8. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
[TBL] [Abstract][Full Text] [Related]
9. Risk assessment and prophylaxis for VTE in cancer patients.
Khorana AA
J Natl Compr Canc Netw; 2011 Jul; 9(7):789-97. PubMed ID: 21715725
[TBL] [Abstract][Full Text] [Related]
10. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment models for cancer-associated venous thromboembolism.
Dutia M; White RH; Wun T
Cancer; 2012 Jul; 118(14):3468-76. PubMed ID: 22086826
[TBL] [Abstract][Full Text] [Related]
12. New strategies of VTE prevention in cancer patients.
Verso M; Agnelli G
Thromb Res; 2014 May; 133 Suppl 2():S128-32. PubMed ID: 24862133
[TBL] [Abstract][Full Text] [Related]
13. Primary prophylaxis of VTE in cancer outpatients.
Imberti D; Benedetti R
Thromb Res; 2016 Apr; 140 Suppl 1():S103-8. PubMed ID: 27067962
[TBL] [Abstract][Full Text] [Related]
14. Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.
Ay C; Pabinger I
Thromb Res; 2012 Apr; 129 Suppl 1():S6-9. PubMed ID: 22682135
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism in cancer patients: expanding horizons.
Bergqvist D
Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():19-23. PubMed ID: 12232819
[TBL] [Abstract][Full Text] [Related]
16. Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapy.
Abu Saadeh F; Langhe R; Galvin DM; O Toole SA; O'Donnell DM; Gleeson N; Norris LA
Thromb Res; 2016 Mar; 139():135-41. PubMed ID: 26916311
[TBL] [Abstract][Full Text] [Related]
17. Assessing risk of venous thromboembolism in the patient with cancer.
Khorana AA; Connolly GC
J Clin Oncol; 2009 Oct; 27(29):4839-47. PubMed ID: 19720906
[TBL] [Abstract][Full Text] [Related]
18. Risk stratification for cancer-associated venous thromboembolism.
Connolly GC; Khorana AA
Best Pract Res Clin Haematol; 2009 Mar; 22(1):35-47. PubMed ID: 19285271
[TBL] [Abstract][Full Text] [Related]
19. Risk assessment for cancer-associated thrombosis: what is the best approach?
Khorana AA
Thromb Res; 2012 Apr; 129 Suppl 1():S10-5. PubMed ID: 22682117
[TBL] [Abstract][Full Text] [Related]
20. Improving clinician performance of inpatient venous thromboembolism risk assessment and prophylaxis.
Goldhaber SZ; Ortel TL; Berry CA; Stowell SA; Gardner AJ
Hosp Pract (1995); 2013 Apr; 41(2):123-31. PubMed ID: 23680743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]